An exploration of human γD-crystallin affinity for potential aggregation inhibitors: A molecular docking investigation

These files contain the supplementary material to the article “An exploration of human γD-crystallin affinity for potential aggregation inhibitors: A molecular docking investigation” and the molecular docking simulation data.

In this study, we performed a comparative molecular docking analysis of several experimentally investigated molecules of natural origin, that might protect γ-crystallins from destabilization and aggregation. Our specific protein targets are wild-type human γD-crystallin, and its mutant P23T γD-crystallin, associated with congenital cataract. Thirteen phytochemicals were investigated as potential inhibitors of γD-crystallin aggregation, and we compared their binding energies with those of lanosterol, an ingredient present in over-the-counter eye products, to prevent cataracts. We performed a detailed comparative molecular docking analysis and we found that the binding energies of lanosterol outcompete those of all the other investigated potential natural inhibitors.